Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular Treatment of Asymptomatic Carotid Artery Stenosis
NCT06899399Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2024
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Composite of stroke, myocardial infarction, or death within 30 days, and ipsilateral stroke from 30 days to 1 year. Started Oct 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06899399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06899399.